OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survival

Daniel Abramowicz, Douglas J. Norman, Pierre Vereerstraeten, Michel Goldman, Luc De Pauw, Jean Louis Vanherweghem, Paul Kinnaert, Lawrence Kahana, Frank P. Stuart, James R. Thistlethwaite, Charles F. Shield, Anthony Monaco, Shu Chen Wu, Thomas P. Haverty

Research output: Contribution to journalArticle

41 Scopus citations

Abstract

The data on patients participating in two randomized, prospective studies with similar immunosuppressive regimens were updated and combined to evaluate the long-term effects of OKT3 according to cold ischemia lime (≤ or > 24 hr). Among 159 patients in the OKT3 and 153 in the cyclosporine A (CsA) group, 8 and 12 deaths occurred, respectively (P = NS). In patients with cold ischemia > 24 hours, OKT3 prophylaxis resulted in a lower mean number of rejection episodes per patient than did CsA prophylaxis within one year (mean ± SEM: 0.87 ± 0.11 vs. 1.35 ± 0.14, respectively; P = 0.008) and within five years (1.07 ± 0.12 vs. 1.49 ± 0.15, respectively; P = 0.032). In contrast, rejection incidences in patients with cold ischemia ≤ 24 hours was not significantly different in the two groups. In all study patients, there was a trend towards higher graft survival rates in the OKT3 group versus the CsA group (at 5 years, 73% vs. 66%, respectively; P = 0.182). Among recipients of kidneys with cold ischemia times > 24 hours, OKT3 patients had significantly higher graft survival than CsA patients at two years (84% vs. 64%, respectively) and at five years (71% vs. 56%, respectively; P = 0.045). Significant differences were not observed in recipients of kidneys with cold ischemia times ≤ 24 hours. In conclusion, patients receiving renal grafts with long cold ischemia times strongly benefit from OKT3 prophylaxis.

Original languageEnglish (US)
Pages (from-to)768-772
Number of pages5
JournalKidney International
Volume49
Issue number3
DOIs
StatePublished - Jan 1 1996

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survival'. Together they form a unique fingerprint.

  • Cite this

    Abramowicz, D., Norman, D. J., Vereerstraeten, P., Goldman, M., De Pauw, L., Vanherweghem, J. L., Kinnaert, P., Kahana, L., Stuart, F. P., Thistlethwaite, J. R., Shield, C. F., Monaco, A., Wu, S. C., & Haverty, T. P. (1996). OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survival. Kidney International, 49(3), 768-772. https://doi.org/10.1038/ki.1996.106